Lazard Asset Management
XTNT icon

Lazard Asset Management’s Xtant Medical Holdings XTNT Stock Holding History

Lazard Asset Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,562
Closed -$10.9K – 2146
2026
Q1 		$10.9K Sell
19,562
-3,158
-14% -$1.94K ﹤0.01% 1823
2025
Q4 		$17.8K Buy
+22,720
New +$16.5K ﹤0.01% 1832

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lazard Asset Management's XTNT Position: Q2 2026 in Review

Lazard Asset Management sold out of Xtant Medical Holdings (XTNT) in Q2 2026, closing a stake of 19,562 shares — an estimated $10.9K sold.

Lazard Asset Management first reported a position in XTNT in Q4 2025 and held it in 2 quarters. The position peaked at $17.8K in Q4 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

  • Lazard Asset Management reported no remaining Xtant Medical Holdings position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 19,562 Xtant Medical Holdings shares in Q2 2026, an estimated $10.9K.
  • Lazard Asset Management first reported a position in Xtant Medical Holdings in Q4 2025 and held it in 2 quarters.
  • Lazard Asset Management's Xtant Medical Holdings position peaked at $17.8K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.